Surmodics, Inc.

Surmodics provides performance coating technologies for intravascular medical devices and IVD tests/microarrays. It operates through two segments: Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment offers surface modification coatings and drug-delivery coatings for various markets. The IVD segment develops, manufactures, and sells chemical/biological components for IVD immunoassay and molecular tests.

Overview

Sector

Medical Devices

Target Price

0.0 USD

Current Price

43.0 USD

Potential

-100%

Strengths

No significant strengths identified based on the analyzed metrics.

Weaknesses

With a depreciation Potential of -100.00%, based on our fundamental analysis, it suggests the stock may be overvalued.
Earnings are projected to decline (-10.0% per year).
The company has high debt. Net Debt to EBITDA Ratio (100.00) is higher than the sector mean.
The company have lower returns than the sector in which it operates. ROIC (0.16%) is significantly lower than the sector mean (2.97%).
EV/EBIT (100.00) is significantly higher than the sector mean.
EBITDA Margin (2.42%) appears relatively low.

Indicator	Value
PER	100.0
EV/EBITDA	201.0
Price/Free Cash Flow'	100.0
ROIC	0.2%
Net Debt/EBITDA	100.0

Surmodics, Inc.

Overview

Strengths

Weaknesses

Key Financial Data